<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.docmoates.com/index.php?action=history&amp;feed=atom&amp;title=Digoxin</id>
	<title>Digoxin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.docmoates.com/index.php?action=history&amp;feed=atom&amp;title=Digoxin"/>
	<link rel="alternate" type="text/html" href="https://wiki.docmoates.com/index.php?title=Digoxin&amp;action=history"/>
	<updated>2026-06-17T16:54:20Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.42.4</generator>
	<entry>
		<id>https://wiki.docmoates.com/index.php?title=Digoxin&amp;diff=4849&amp;oldid=prev</id>
		<title>Docmoates: Add medication infobox (Drugbox) to monographs</title>
		<link rel="alternate" type="text/html" href="https://wiki.docmoates.com/index.php?title=Digoxin&amp;diff=4849&amp;oldid=prev"/>
		<updated>2026-06-17T16:09:20Z</updated>

		<summary type="html">&lt;p&gt;Add medication infobox (Drugbox) to monographs&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 16:09, 17 June 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{Drugbox&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| name = Digoxin&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| brand = Lanoxin&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| therapeutic = Heart failure agent, antiarrhythmic&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| pharmacologic = Cardiac glycoside (NTI)&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| onset = PO onset 1 to 2 hours; IV onset 5 to 30 minutes; duration 3 to 4 days.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| halflife = Half-life 36 to 48 hours; therapeutic level about 0.5 to 2 ng/mL (lower, around 0.5 to 0.9 ng/mL, preferred in heart failure).&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| routes = PO (oral)&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| highalert = &amp;lt;span style=&quot;color:#b00020;&quot;&amp;gt;&#039;&#039;&#039;Yes&#039;&#039;&#039;&amp;lt;/span&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| blackbox = None&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| antidote = Digoxin immune Fab (DigiFab) for severe toxicity.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| pregnancy = Used when clearly needed.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;div style=&amp;quot;border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;&amp;quot;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;div style=&amp;quot;border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;&amp;quot;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and &amp;#039;&amp;#039;&amp;#039;must be verified against current manufacturer labeling before clinical use&amp;#039;&amp;#039;&amp;#039;. This is educational content, not prescribing guidance.&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and &amp;#039;&amp;#039;&amp;#039;must be verified against current manufacturer labeling before clinical use&amp;#039;&amp;#039;&amp;#039;. This is educational content, not prescribing guidance.&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Docmoates</name></author>
	</entry>
	<entry>
		<id>https://wiki.docmoates.com/index.php?title=Digoxin&amp;diff=3969&amp;oldid=prev</id>
		<title>Docmoates: NCLEX nursing pharmacology monographs — batch import</title>
		<link rel="alternate" type="text/html" href="https://wiki.docmoates.com/index.php?title=Digoxin&amp;diff=3969&amp;oldid=prev"/>
		<updated>2026-06-17T13:37:15Z</updated>

		<summary type="html">&lt;p&gt;NCLEX nursing pharmacology monographs — batch import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;div style=&amp;quot;border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;&amp;quot;&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and &amp;#039;&amp;#039;&amp;#039;must be verified against current manufacturer labeling before clinical use&amp;#039;&amp;#039;&amp;#039;. This is educational content, not prescribing guidance.&amp;#039;&amp;#039;&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Digoxin&amp;#039;&amp;#039;&amp;#039; (brand name Lanoxin) &amp;amp;mdash; Heart failure agent, antiarrhythmic; Cardiac glycoside (NTI).&lt;br /&gt;
&lt;br /&gt;
== Identification ==&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Therapeutic class:&amp;#039;&amp;#039;&amp;#039; Heart failure agent, antiarrhythmic.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Pharmacologic class:&amp;#039;&amp;#039;&amp;#039; Cardiac glycoside (NTI).&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Mechanism of action:&amp;#039;&amp;#039;&amp;#039; Inhibits the sodium-potassium pump to increase intracellular calcium and contractility (positive inotrope), and slows AV conduction to reduce heart rate.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Onset / peak / duration:&amp;#039;&amp;#039;&amp;#039; PO onset 1 to 2 hours; IV onset 5 to 30 minutes; duration 3 to 4 days.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Half-life / therapeutic level:&amp;#039;&amp;#039;&amp;#039; Half-life 36 to 48 hours; therapeutic level about 0.5 to 2 ng/mL (lower, around 0.5 to 0.9 ng/mL, preferred in heart failure).&lt;br /&gt;
&lt;br /&gt;
== Clinical use ==&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Indications:&amp;#039;&amp;#039;&amp;#039; Heart failure, atrial fibrillation rate control.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Usual dose, route, frequency:&amp;#039;&amp;#039;&amp;#039; 0.125 to 0.25 mg PO daily, sometimes with a loading approach.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Maximum dose / adjustments:&amp;#039;&amp;#039;&amp;#039; Reduce dose in renal impairment and in the elderly; hypokalemia greatly increases toxicity risk.&lt;br /&gt;
&lt;br /&gt;
== Safety ==&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Contraindications:&amp;#039;&amp;#039;&amp;#039; Ventricular fibrillation, second or third degree heart block without pacemaker.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Black box warning:&amp;#039;&amp;#039;&amp;#039; None formal; narrow therapeutic index demands careful monitoring.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Interactions:&amp;#039;&amp;#039;&amp;#039; Diuretics (hypokalemia raises toxicity), amiodarone, verapamil, and quinidine (raise digoxin levels); hawthorn and licorice (herbal) affect levels and potassium.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Pregnancy / lactation:&amp;#039;&amp;#039;&amp;#039; Used when clearly needed.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;High-alert:&amp;#039;&amp;#039;&amp;#039; Yes.&lt;br /&gt;
&lt;br /&gt;
== Adverse effects ==&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Common side effects:&amp;#039;&amp;#039;&amp;#039; Bradycardia, nausea, fatigue.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Serious effects to report:&amp;#039;&amp;#039;&amp;#039; Toxicity signs: anorexia, nausea, vomiting, visual changes (yellow or green halos), confusion, arrhythmias.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Antidote / reversal:&amp;#039;&amp;#039;&amp;#039; Digoxin immune Fab (DigiFab) for severe toxicity.&lt;br /&gt;
&lt;br /&gt;
== Nursing process ==&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Assessment before administration:&amp;#039;&amp;#039;&amp;#039; Apical pulse for one full minute, potassium, renal function, digoxin level.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Interventions during therapy:&amp;#039;&amp;#039;&amp;#039; Hold and notify if apical pulse is below 60 in adults; correct hypokalemia.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Monitor:&amp;#039;&amp;#039;&amp;#039; Apical heart rate, potassium, renal function, digoxin level, ECG.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Evaluation / expected outcome:&amp;#039;&amp;#039;&amp;#039; Improved heart failure symptoms, controlled ventricular rate.&lt;br /&gt;
&lt;br /&gt;
== Patient teaching ==&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Patient teaching:&amp;#039;&amp;#039;&amp;#039; Learn to take your pulse; report nausea or vision changes.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Notify provider if:&amp;#039;&amp;#039;&amp;#039; Pulse below 60, nausea or appetite loss, yellow or green vision, confusion.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Administration tips:&amp;#039;&amp;#039;&amp;#039; Same time daily; do not take with high-fiber meals at the same time; do not double doses.&lt;br /&gt;
&lt;br /&gt;
[[Category:Antiarrhythmics and Specialty Cardiac Agents]]&lt;/div&gt;</summary>
		<author><name>Docmoates</name></author>
	</entry>
</feed>